Contemporary use of SGLT2i therapy among patients hospitalized for heart failure with reduced ejection fraction in the United States

被引：0
|
作者：
Pierce, J. B. [1 ]
Vaduganathan, M. [2 ]
Fonarow, G. C. [3 ]
Ikeaba, U. [4 ]
Chiswell, K. [4 ]
Huang, J. [5 ]
Linganathan, K. [5 ]
Mcdermott, J. [5 ]
Greene, S. J. Stephen [4 ]
机构：
[1] Duke Univ, Sch Med, Durham, NC 27706 USA
[2] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[4] Duke Clin Res Inst, Durham, NC USA
[5] AstraZeneca, Wilmington, DE USA
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：66 / 67
页数：2
相关论文
共 50 条
  • [21] SGLT2 inhibitors in heart failure with reduced ejection fraction
    Uday Sankar Das
    Aritra Paul
    Suvro Banerjee
    The Egyptian Heart Journal, 73
  • [22] SGLT2i-treated heart failure patients with a reduced ejection fraction: A meta-analysis
    Ye, Qiang
    Zha, Kelan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (06)
  • [23] STRATEGIES TO OPTIMISE GUIDELINE-DIRECTED MEDICAL THERAPY IN HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION BY IMPROVING SGLT2I INITIATION RATES IN NURSE-LED OUTPATIENT HEART FAILURE CLINICS
    Soh, Bwt
    Cusack, R.
    O'Brien, K.
    Glasgow, J.
    Forkin, A.
    Abbas, S.
    Arnous, S.
    Kiernan, T.
    HEART, 2022, 108 : A51 - A53
  • [24] A CASE OF METABOLIC ACIDOSIS AFTER INITIATION OF SGLT2-I THERAPY IN HEART FAILURE WITH REDUCED EJECTION FRACTION
    D'Errico, G.
    Orso, F.
    Verga, F.
    Salucci, C.
    Perini, E.
    Vatri, M.
    Poletti, E.
    Cagnoni, C.
    Corti, G.
    Di Bari, M.
    Ungar, A.
    Baldasseroni, S.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [25] Time to SGLT2i Initiation in Patients With Heart Failure
    Moon, Jungyeon
    Udell, Jacob A.
    Chong, Alice
    Fang, Jiming
    Austin, Peter
    Ko, Dennis T.
    Stukel, Therese
    Atzema, Clare
    Booth, Gillian
    Tu, Karen
    Naimark, David
    Jackevicius, Cynthia
    CIRCULATION, 2023, 148
  • [26] Contemporary Pillars of Heart Failure with Reduced Ejection Fraction Medical Therapy
    Rahamim, Eldad
    Nachman, Dean
    Yagel, Oren
    Yarkoni, Merav
    Elbaz-Greener, Gabby
    Amir, Offer
    Asleh, Rabea
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [27] Improving management of heart failure with reduced ejection fraction with sglt2i's using the latest clinical data: an online education intervention
    Sattin, S.
    Sendaydiego, A. M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 780 - 780
  • [28] Ejection Fraction and Mortality in Elderly Patients Hospitalized With Heart Failure: Is Preserved Ejection Fraction Comparable to Reduced Ejection Fraction?
    Rathore, Saif S.
    Chen, Jersey
    Wang, Yongfei
    Curtis, Jeptha P.
    Masoudi, Frederick A.
    Krumholz, Harlan M.
    CIRCULATION, 2009, 120 (18) : S750 - S750
  • [29] Could sweet pee be the answer? Applicability of use of sodium-glucose co-transporter-2 inhibitors (SGLT2i) in patients with heart failure with reduced ejection fraction (HFrEF)
    Sharma, A.
    Lakra, O.
    Al-Dulaimi, Z.
    Sethi, J.
    Shah, J.
    Hui, E.
    DIABETIC MEDICINE, 2021, 38
  • [30] Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction
    Greene, Stephen J.
    Choi, Sujung
    Lippmann, Steven J.
    Mentz, Robert J.
    Greiner, Melissa A.
    Hardy, N. Chantelle
    Hammill, Bradley G.
    Luo, Nancy
    Samsky, Marc D.
    Heidenreich, Paul A.
    Laskey, Warren K.
    Yancy, Clyde W.
    Peterson, Pamela N.
    Curtis, Lesley H.
    Hernandez, Adrian F.
    Fonarow, Gregg C.
    O'Brien, Emily C.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (16):
12345